Local failure in resected N1 lung cancer: implications for adjuvant therapy.

[1]  J. Flickinger,et al.  Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[2]  A. Yılmaz,et al.  Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  J. Luketich,et al.  Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[4]  Jose Belderbos,et al.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  N. Altorki,et al.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. , 2010, The Journal of thoracic and cardiovascular surgery.

[6]  G. Chang,et al.  Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. , 2009, The Journal of thoracic and cardiovascular surgery.

[7]  R. Rosell,et al.  Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. , 2008, International journal of radiation oncology, biology, physics.

[8]  Richard J Stephens,et al.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L. Wilson,et al.  Postoperative radiation therapy for lung cancer: where do we stand? , 2008, Oncology.

[10]  Julio Astudillo,et al.  Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. , 2006, The Lancet. Oncology.

[11]  L. Marks,et al.  Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. , 2006, International journal of radiation oncology, biology, physics.

[12]  L. Wilson,et al.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  V. Rousson,et al.  Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. , 2005, The Annals of thoracic surgery.

[14]  Robert Livingston,et al.  Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.

[15]  C. Kang,et al.  Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. , 2005, The Annals of thoracic surgery.

[16]  M. Cowles.  Modelling Survival Data in Medical Research (2nd ed.) (Book) , 2004 .

[17]  K. Yasumoto,et al.  Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. , 2004, Lung cancer.

[18]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[19]  L. Voltolini,et al.  Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? , 2003, The Journal of cardiovascular surgery.

[20]  W. Yin,et al.  A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[21]  H. Li,et al.  Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.

[22]  S. Burdett,et al.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.

[23]  M. Parmar,et al.  Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.

[24]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[25]  W. Fry,et al.  Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. , 1981, The Annals of thoracic surgery.

[26]  Nohl-Oser Hc.  An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma. , 1972 .

[27]  Edward L. Melnick,et al.  Modeling Survival Data , 2011, International Encyclopedia of Statistical Science.